Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Drug Design Development and Therapy
JournalCitation impact & published research
Drug Design Development and Therapy is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 5,796 works, 143,482 citations, an h-index of 129 and an APC (USD) of 2,836.
5,796
Works
143,482
Citations
129
h-index
2,836
APC (USD)
IDs:OpenAlex
What are the most-cited papers on Drug Design Development and Therapy?
ScholarIQmost cited works
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
Assumpta Caixàs, Lara Albert, Ismael Capel, Mercedes Rigla
Drug Design Development and Therapy. 2014235 CitationsOPEN ACCESS
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
Edward M. Wolin, Barbara Jarząb, Barbro Eriksson, Thomas Walter, Christos Toumpanakis, Michael A. Morse, Paola Tomassetti, Matthias M. Weber, David R. Fogelman, John Ramage, Donald Poon, Brian Gadbaw, Li Jiang, Janice L. Pasieka, Abakar Mahamat, Fredrik Swahn, John Newell‐Price, Wasat Mansoor, Kjell Öberg
Drug Design Development and Therapy. 2015209 CitationsOPEN ACCESS
The Risks of miRNA Therapeutics: In a Drug Target Perspective
Song Zhang, Zhujun Cheng, Yanan Wang, Tianyu Han
Drug Design Development and Therapy. 2021208 CitationsOPEN ACCESS
Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria
Xiaozhe Wu, Zhan Li, Xiaolu Li, Yaomei Tian, Yingzi Fan, Chaoheng Yu, Bailing Zhou, Yi Liu, Rong Xiang, Yang Li
Drug Design Development and Therapy. 2017144 CitationsOPEN ACCESS
Tocilizumab in the treatment of rheumatoid arthritis and beyond
Nadera Sweiss, Anjali Shetty, Rebekah L. Hanson, Peter Korsten, Shiva Arami, Suncica Volkov, Olga M Vila, William Swedler, Shiva Shahrara, Sameer Smadi, Ray Sawaqued, Munir Shawagfeh, Abdel Naser Shunaigat, David W. Perkins
Drug Design Development and Therapy. 2014107 CitationsOPEN ACCESS
Related on ScholarIQ
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
Paper
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
Paper
The Risks of miRNA Therapeutics: In a Drug Target Perspective
Paper
Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria
Paper
Tocilizumab in the treatment of rheumatoid arthritis and beyond
Paper
A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer
Paper